| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2afec86507fc41d4fd24a6693763f876
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44f04d319aaa6e66f240244bc905f452 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-413
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-762
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-318 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-064 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D61-14 |
| filingDate |
2017-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e52c082301bb865869930957ab56091f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce5b460d33fe6f7c4ee49ac06bf61822
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_079767274be42805398c7ad9fba70348
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d29ae5151ad8984cb9582a8dff3870b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d29f589a5c42e0c0c193be025983120
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_228006fc9f3d6a816d9426888c437abd |
| publicationDate |
2021-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-I750192-B |
| titleOfInvention |
Use of extracellular vesicles isolated from beer in manufacturing an anti-inflammatory composition |
| abstract |
The present disclosure discloses an anti-inflammatory composition ncomprising extracellular vesicles derived from yeast as an active ingredient and an anti-inflammatory composition comprising extracellular vesicles derived from a food comprising yeast as an active ingredient. In one aspect, the yeast may be Saccharomyces cerevisiae . The anti-inflammatory composition suppresses or inhibits the secretion of the inflammatory mediators tumor necrosis factor-α (TNF-α) or interleukin-6 (IL-6). |
| priorityDate |
2016-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |